WCN26-2329 THE IMPACT OF POLYPHARMACY DUE TO NON-CKD MEDICATIONS AMONG CKD PATIENTS

Read full text Summarise with VIRAT
Authors: Hiroshi Kimura, Kenichi Tanaka, Hirotaka Saito, Syuhei Watanabe, Michio Shimabukuro, Koichi Asahi, Tsuyoshi Watanabe, Junichiro James Kazama
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Polypharmacy is common in patients with chronic kidney disease (CKD) and is associated with several adverse outcomes. However, its impact on medications for the management of CKD and non-CKD has not been adequately elucidated. Therefore, we aimed to investigate relationships among polypharmacy, medication for CKD management, and renal prognosis, mortality, and cardiovascular events in patients with CKD.

Fields of Study & Subjects

Pharmaceutical Practices and Patient Outcomes Dialysis and Renal Disease Management Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104303–104303
Publication date
25 March 2026
Language
EN